Brighton Jones LLC Baxter International Inc Transaction History

Brighton Jones LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$63.83 - $80.0 $186,894 - $234,240	-2,928 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$76.85 - $89.45 $2,997 - $3,488	39 Added 1.35%	2,928 $227,000
Q4 2021 Feb 03, 2022	BUY	$74.57 - $87.19 $1,043 - $1,220	14 Added 0.49%	2,889 $248,000
Q3 2021 Nov 04, 2021	SELL	$73.77 - $83.61 $39,983 - $45,316	-542 Reduced 15.86%	2,875 $231,000
Q2 2021 Aug 10, 2021	BUY	$80.5 - $88.01 $6,520 - $7,128	81 Added 2.43%	3,417 $275,000
Q1 2021 May 07, 2021	SELL	$76.38 - $86.03 $5,270 - $5,936	-69 Reduced 2.03%	3,336 $281,000
Q4 2020 Feb 10, 2021	BUY	$75.39 - $82.36 $52,999 - $57,899	703 Added 26.02%	3,405 $273,000
Q3 2020 Nov 12, 2020	SELL	$78.33 - $90.73 $4,386 - $5,080	-56 Reduced 2.03%	2,702 $217,000
Q2 2020 Aug 11, 2020	BUY	$78.66 - $94.14 $7,079 - $8,472	90 Added 3.37%	2,758 $237,000
Q1 2020 May 13, 2020	SELL	$71.57 - $93.3 $7,300 - $9,516	-102 Reduced 3.68%	2,668 $217,000
Q4 2019 Feb 07, 2020	BUY	$76.7 - $88.45 $1,917 - $2,211	25 Added 0.91%	2,770 $232,000
Q3 2019 Oct 28, 2019	BUY	$81.4 - $89.78 $1,709 - $1,885	21 Added 0.77%	2,745 $240,000
Q2 2019 Aug 05, 2019	SELL	$73.44 - $82.41 $6,536 - $7,334	-89 Reduced 3.16%	2,724 $223,000
Q1 2019 Apr 26, 2019	BUY	$64.48 - $81.31 $181,382 - $228,725	2,813 New	2,813 $229,000
Q4 2018 Feb 08, 2019	SELL	$61.45 - $77.8 $189,020 - $239,312	-3,076 Closed	0 $0
Q3 2018 Nov 07, 2018	SELL	$70.71 - $77.75 $2,333 - $2,565	-33 Reduced 1.06%	3,076 $237,000
Q2 2018 Aug 06, 2018	BUY	$63.43 - $75.41 $197,203 - $234,449	3,109 New	3,109 $230,000

1,006

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.7B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

Stay updated on Brighton Jones LLC with notifications on news.